Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study to Assess the Safety of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

NCT01525602 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT01525602
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01525602 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study to Assess the Safety of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors
Lead sponsor
Daiichi Sankyo
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2012
Completion date
February 28, 2018
Enrollment
74 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumors